1. Baba, K., X.Y. Qing, M. Taniguchi, M. Kozawa, and E. Fujita. 1991. Studies on Chinese medicine “Fang-Feng”, (III): Constituents of Shui-Fang-Feng. Shoyakugaku Zasshi 45(167–1): 73.
2. Barreiro, O., P. Martin, R. Gonzalez-Amaro, and F. Sanchez-Madrid. 2010. Molecular cues guiding inflammatory responses. Cardiovascular Research 86(174–1): 82.
3. Burke, A., E. Smyth, and G.A. Fitzgerald. 2006. Analgesic-antipyretic agents: pharmacotherapy of gout. In Goodman and Gilman’s: The pharmacological basis of therapeutics, ed. L.L. Brunton, J.S. Lazo, and K.L. Parker, 706. New York: McGraw Hill.
4. Chai, H., Q. Wang, L. Huang, T. Xie, and Y. Fu. 2008. Ginsenoside Rb1 inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Biological and Pharmaceutical Bulletin 31: 2050–2056.
5. Chao, W.W., and B.F. Lin. 2011. Bioactivities of major constituents isolated from Angelica sinensis (Danggui). Chinese Medicine 6: 29.